Cyrus Harmon
Founder presso OLEMA PHARMACEUTICALS, INC.
Patrimonio netto: 11 M $ in data 31/03/2024
Profilo
Cyrus L.
Harmon is the founder.
He founded Neomorphics, Inc. in 1996, where he served as the Chief Executive Officer from 1996 to 2000.
He also founded Olema Pharmaceuticals, Inc. in 2006 and currently holds the title of Director.
In addition to his founding positions, Dr. Harmon previously worked at Affymetrix, Inc. as the General Manager from 2000 to 2002.
Dr. Harmon obtained his undergraduate and doctorate degrees from the University of California, Berkeley.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 28/03/2024 | 948 311 ( 1.70% ) | 11 M $ | 31/03/2024 |
Posizioni attive di Cyrus Harmon
| Società | Posizione | Inizio |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Founder | 07/08/2006 |
Precedenti posizioni note di Cyrus Harmon
| Società | Posizione | Fine |
|---|---|---|
| AFFYMETRIX, INC. | Corporate Officer/Principal | 01/01/2002 |
Neomorphics, Inc.
 Neomorphics, Inc. Medical SpecialtiesHealth Technology Neomorphics, Inc. develops, analyzes, and manages genetic information to improve disease. The company is based in Berkeley, CA. The company was founded by Cyrus L. Harmon, Martin G. Reese. Neomorphics was acquired by Affymetrix, Inc., part of Thermo Fisher Scientific, Inc. from April 01, 2016 on October 31, 2000 for $85.92 million. | Chief Executive Officer | 01/01/2000 |
Formazione di Cyrus Harmon
| University of California, Berkeley | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| OLEMA PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Affymetrix, Inc.
 Affymetrix, Inc. Medical SpecialtiesHealth Technology Affymetrix, Inc. develops, manufactures and sells products and services for genetic analysis. The company was founded by Stephen P. A. Fodor in 1992 and is headquartered in Santa Clara, CA. | Health Technology |
Neomorphics, Inc.
Neomorphics, Inc. Medical SpecialtiesHealth Technology Neomorphics, Inc. develops, analyzes, and manages genetic information to improve disease. The company is based in Berkeley, CA. The company was founded by Cyrus L. Harmon, Martin G. Reese. Neomorphics was acquired by Affymetrix, Inc., part of Thermo Fisher Scientific, Inc. from April 01, 2016 on October 31, 2000 for $85.92 million. | Health Technology |
- Borsa valori
- Insiders
- Cyrus Harmon
